Aridis Pharmaceuticals (ARDS) Short Interest Ratio & Short Volume → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free ARDS Stock Alerts $0.08 +0.00 (+4.28%) (As of 05:45 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Aridis Pharmaceuticals Short Interest DataCurrent Short Volume2,430,000 sharesPrevious Short Volume2,000,000 sharesChange Vs. Previous Month+21.50%Dollar Volume Sold Short$774,927.00Short Interest Ratio / Days to Cover0.5Last Record DateJuly 15, 2023Outstanding Shares47,930,000 sharesPercentage of Shares Shorted5.07%Today's Trading Volume18,884 sharesAverage Trading Volume106,324 sharesToday's Volume Vs. Average18% Short Selling Aridis Pharmaceuticals ? Sign up to receive the latest short interest report for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatARDS Short Interest Over TimeARDS Days to Cover Over TimeARDS Percentage of Float Shorted Over Time Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Aridis Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20232,430,000 shares $774,927.00 +21.5%N/A0.5 $0.32 6/30/20232,000,000 shares $439,800.00 +8.1%N/A0.6 $0.22 6/15/20231,850,000 shares $499,315.00 +320.7%N/A0.5 $0.27 5/31/2023439,700 shares $174,736.78 -41.9%N/A0.1 $0.40 5/15/2023756,200 shares $161,221.84 +87.0%N/A0.9 $0.21 4/30/2023404,400 shares $72,711.12 -29.5%N/A0.4 $0.18 Get the Latest News and Ratings for ARDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 4/15/2023573,300 shares $126,126.00 +0.3%N/A0.4 $0.22 3/31/2023571,400 shares $179,476.74 -81.3%N/A0.4 $0.31 3/15/20233,060,000 shares $1.27 million +323.8%N/A2 $0.41 2/28/2023722,100 shares $407,264.40 +2.6%N/A0.8 $0.56 2/15/2023703,900 shares $436,418.00 +7.6%N/A0.8 $0.62 1/31/2023654,300 shares $438,381.00 +1,125.3%N/A0.8 $0.67 1/15/202353,400 shares $68,085.00 -44.3%N/A0.2 $1.28 12/30/202295,900 shares $113,162.00 -51.1%N/A0.9 $1.18 12/15/2022196,200 shares $198,162.00 +120.0%N/A1.2 $1.01 11/30/202289,200 shares $81,172.00 -8.0%N/A0.6 $0.91 11/15/202297,000 shares $81,480.00 -7.6%N/A0.7 $0.84 10/31/2022105,000 shares $109,200.00 -49.8%N/A0.7 $1.04 10/15/2022209,000 shares $204,903.60 -55.9%N/A1 $0.98 9/30/2022473,500 shares $440,355.00 +276.7%N/A2.3 $0.93 9/15/2022125,700 shares $227,517.00 +42.2%N/A1.1 $1.81 8/31/202288,400 shares $129,064.00 -53.4%N/A0.7 $1.46 8/15/2022189,700 shares $415,443.00 +53.2%N/A1.5 $2.19 7/31/2022123,800 shares $305,786.00 +28.0%N/A1 $2.47 7/15/202296,700 shares $106,370.00 +3.5%N/A1.8 $1.10 6/30/202293,400 shares $102,740.00 -50.2%N/A1.7 $1.10 6/15/2022187,700 shares $268,411.00 +0.9%N/A2.9 $1.43 5/31/2022186,000 shares $213,900.00 +114.5%N/A2.6 $1.15 5/15/202286,700 shares $80,891.10 -20.8%N/A0.6 $0.93 4/30/2022109,500 shares $136,875.00 +52.1%N/A0.3 $1.25 4/15/202272,000 shares $103,680.00 -36.3%N/A0.1 $1.44 3/31/2022113,000 shares $198,880.00 +32.0%1.2%0.1 $1.76 3/15/202285,600 shares $130,112.00 -55.0%0.9%0 $1.52 2/28/2022190,000 shares $380,000.00 -77.5%2.0%0.1 $2.00 2/15/2022844,900 shares $2.07 million -67.6%8.9%0.4 $2.45 1/31/20222,610,000 shares $4.72 million +1,272.2%27.6%1.2 $1.81 1/15/2022190,200 shares $292,908.00 +45.9%2.0%0.1 $1.54 12/31/2021130,400 shares $303,832.00 +3,004.8%1.4%0.1 $2.33 12/15/20214,200 shares $9,156.00 -82.1%0.0%0 $2.18 11/30/202123,500 shares $53,110.00 +360.8%0.3%0.7 $2.26$25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. ARDS Short Interest - Frequently Asked Questions What is Aridis Pharmaceuticals' current short interest? Short interest is the volume of Aridis Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 2,430,000 shares of ARDS short. Learn More on Aridis Pharmaceuticals' current short interest. Is Aridis Pharmaceuticals' short interest increasing or decreasing? Aridis Pharmaceuticals saw a increase in short interest in July. As of July 15th, there was short interest totaling 2,430,000 shares, an increase of 21.5% from the previous total of 2,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Aridis Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aridis Pharmaceuticals: Kintara Therapeutics, Inc. (5.64%), Jaguar Health, Inc. (14.66%), Petros Pharmaceuticals, Inc. (6.75%), PaxMedica, Inc. (8.77%), Altamira Therapeutics Ltd. (3.91%), Notable Labs, Ltd. (0.13%), Biophytis S.A. (0.44%), Atreca, Inc. (0.37%), PainReform Ltd. (1.02%), Synaptogenix, Inc. (2.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($3.75 billion), Charter Communications, Inc. ($3.17 billion), Occidental Petroleum Co. ($2.86 billion), Rivian Automotive, Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.13 billion), Royal Caribbean Cruises Ltd. ($2.05 billion), Palantir Technologies Inc. ($2.04 billion), Extra Space Storage Inc. ($1.98 billion), Enphase Energy, Inc. ($1.66 billion), and Tractor Supply ($1.61 billion). View all of the most shorted stocks. What does it mean to sell short Aridis Pharmaceuticals stock? Short selling ARDS is an investing strategy that aims to generate trading profit from Aridis Pharmaceuticals as its price is falling. ARDS shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aridis Pharmaceuticals? A short squeeze for Aridis Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ARDS, which in turn drives the price of the stock up even further. How often is Aridis Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARDS, twice per month. The most recent reporting period available is July, 15 2023. More Short Interest Resources from MarketBeat Related Companies: Kintara Therapeutics Short Interest Jaguar Health Short Interest Petros Pharmaceuticals Short Interest PaxMedica Short Interest Altamira Therapeutics Short Interest Notable Labs Short Interest Biophytis Short Interest Atreca Short Interest PainReform Short Interest Synaptogenix Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARDS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory